Cases 1 - 10 of 1,694
Breckenridge Pharmaceutical, Inc. v. Hetero USA Inc. et al
as 1:2024cv00571
Plaintiff:
Breckenridge Pharmaceutical, Inc.
Defendant:
Hetero USA Inc., Hetero Labs Limited Unit - III, Hetero Labs Limited. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Regeneron Pharmaceuticals, Inc. v. Amgen, Inc.
as 1:2024cv00039
Plaintiff:
Regeneron Pharmaceuticals, Inc.
Counter Claimant:
Amgen, Inc.
Cause Of Action: 28 U.S.C. § 1338 Patent Infringement
In Re: Aflibercept Patent Litigation
as 1:2024md03103
Not Yet Classified:
AFLIBERCEPT PATENT LITIGATION
Plaintiff:
Regeneron Pharmaceuticals, Inc.
Defendant:
Mylan Pharmaceuticals, Inc., AMGEN USA, INC., BIOCON BIOLOGICS INC. and others
Cause Of Action: 28 U.S.C. § 1338 Patent Infringement
Progenics Pharmaceuticals, Inc. et al v. MIM Software Inc.
as 1:2024cv10437
Plaintiff:
Progenics Pharmaceuticals, Inc. and EXINI Diagnostics AB
Defendant:
MIM Software Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc.
as 24-1402
Plaintiff:
REGENERON PHARMACEUTICALS, INC.
Defendant:
MYLAN PHARMACEUTICALS INC., BIOCON BIOLOGICS INC. and AMGEN USA, INC.
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc.
as 24-1405
Plaintiff:
REGENERON PHARMACEUTICALS, INC.
Defendant:
MYLAN PHARMACEUTICALS INC., BIOCON BIOLOGICS INC. and AMGEN USA, INC.
Eagle Pharmaceuticals, Inc. v. Apotex Inc. et al
as 1:2024cv00064
Plaintiff:
Eagle Pharmaceuticals, Inc.
Defendant:
Apotex Inc. and Apotex Corp.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Eagle Pharmaceuticals, Inc. v. Baxter Healthcare Corporation
as 1:2024cv00066
Plaintiff:
Eagle Pharmaceuticals, Inc.
Defendant:
Baxter Healthcare Corporation
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Eagle Pharmaceuticals, Inc. v. Slayback Pharma LLC
as 1:2024cv00065
Plaintiff:
Eagle Pharmaceuticals, Inc.
Defendant:
Slayback Pharma LLC
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Regeneron Pharmaceuticals, Inc. v. Amgen, Inc.
as 2:2024cv00264
Plaintiff:
Regeneron Pharmaceuticals, Inc.
Defendant:
Amgen, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
